Huang, Y., Tseng, J., Hsu, K., Chen, K., Su, K., Yu, S., . . . Chang, G. (2021). The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M. Sci Rep.
Chicago Style CitationHuang, Yen-Hsiang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J. W. Chen, Tsung-Ying Yang, and Gee-Chen Chang. "The Impact of Different First-line EGFR-TKIs On the Clinical Outcome of Sequential Osimertinib Treatment in Advanced NSCLC With Secondary T790M." Sci Rep 2021.
MLA CitationHuang, Yen-Hsiang, et al. "The Impact of Different First-line EGFR-TKIs On the Clinical Outcome of Sequential Osimertinib Treatment in Advanced NSCLC With Secondary T790M." Sci Rep 2021.